The 48th edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information will be released in late winter or early spring. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, the Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, the Sanford Guide to Antimicrobial Therapy provides information that is convenient, concise, and reliable.
Coverage includes:
•Clinical syndromes •pathogens
•bacterial
•fungal
•mycobacterial
•parasitic
•viral
•Anti-infective agents •dosing •pediatric adjustments
•renal adjustments
•adverse affects
•activity
•pharmacology
•interactions
•Preventative therapy
목차
What's new in 2018:
•Table 1: meningitis, otitis media, diarrhea, cystitis, UTIs, endocarditis, CAP/HAP/VAP, SBP, appendicitis, pharyngitis, sinusitis, bites, oroya fever/verruga peruna, necrotizing fasciitis, septic shock, thrombophlebitis, botulism
•Table 2: resistant bacteria, including GNB
•Table 3: duration of therapy updated throughout
•Table 4: organism coverage expanded, drugs added (new and old)
•Table 5B: complete update
•Table 9A: recent drugs added
•Table 10A: recent drugs added, e.g., mero-vabor, delaflox, pip-tazo dosing updated, colistin dosing updated, including inhalation (10F)
•Table 11: Isavuconazole indications and dosing
•Table 13: giardia, leishmaniasis, microsporidiosis, malaria, trematodes, cestodes; antiparasitic drug updates (13B, 13D)
•Table 14A: MERS, enterovirus, HSV aseptic meningitis, influenza
•Table 14B: new HCV, CMV drugs
•Table 14C: new ARV drugs
•Table 14F: updated HCV treatment regimens and recommendations
•Table 15A: post-splenectomy bacteremia, asplenia, sickle cell disease
•Table 15B: colorectal, OB-Gyn, ophthalmic and general comments
•Table 16: added peds dosing for additional antibacterials, ARVs, antivirals
•Table 17: renal adjustments for ceftaz-avi, mero-vabor, delaflox
•Table 17C: updated obesity dose adjustments
•Table 17D: NEW list of antibacterials with no need to adjust dose for obesity
•Table 19: comprehensive update to treatment of CAPD peritonitis
•Table 22: added recent drugs
등록된 상품이 없습니다.
사용후기가 없습니다.
상품문의가 없습니다.
